CRT 2026
Heart Failure
Nisha Gilotra, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure information not submitted.
Daniele Massera, MD, MSc
Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States
Disclosure(s): Chiesi Inc: Consulting Fees (e.g., advisory boards) (Terminated, April 30, 2025); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Rocket Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Cynthia Bither, NP
NP, Advanced Heart Failure Program
MedStar Washington Hospital Center
Shady Side, Maryland, United States
Disclosure information not submitted.
Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA
executive director, Krannert Cardiovascular Research Center
Indiana University
Indianapolis, Indiana, United States
Disclosure(s): No financial relationships to disclose
Nisha Gilotra, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure information not submitted.
Mitchell Psotka, MD PhD
System Chief, Heart Failure and Transplant
Inova Schar Heart and Vascular
Falls Church, Virginia, United States
Disclosure(s): No financial relationships to disclose
Tadahisa Sugiura, MD, PhD
Assistant Professor
Montefiore Medical Center/ Albert Einstein College of Medicine
Disclosure(s): No financial relationships to disclose